Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23273
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKalousi, A.en
dc.contributor.authorMylonis, I.en
dc.contributor.authorPolitou, A. S.en
dc.contributor.authorChachami, G.en
dc.contributor.authorParaskeva, E.en
dc.contributor.authorSimos, G.en
dc.date.accessioned2015-11-24T19:31:29Z-
dc.date.available2015-11-24T19:31:29Z-
dc.identifier.issn1477-9137-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/23273-
dc.rightsDefault Licence-
dc.subjectAmino Acid Sequenceen
dc.subjectCasein Kinase Idelta/genetics/*metabolismen
dc.subjectCell Hypoxia/physiologyen
dc.subjectHEK293 Cellsen
dc.subjectHeLa Cellsen
dc.subjectHumansen
dc.subjectHypoxia-Inducible Factor 1/genetics/*metabolismen
dc.subjectHypoxia-Inducible Factor 1, alpha Subunit/metabolismen
dc.subjectModels, Molecularen
dc.subjectMolecular Sequence Dataen
dc.subjectNuclear Proteins/genetics/metabolismen
dc.subjectPhosphorylationen
dc.subjectTranscription Factors/genetics/metabolismen
dc.subjectTranscriptional Activationen
dc.titleCasein kinase 1 regulates human hypoxia-inducible factor HIF-1en
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1242/jcs.068122-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/20699359-
heal.identifier.secondaryhttp://jcs.biologists.org/content/123/17/2976.full.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2010-
heal.abstractHypoxia-inducible factor 1 (HIF-1), a transcriptional activator that mediates cellular response to hypoxia and a promising target of anticancer therapy, is essential for adaptation to low oxygen conditions, embryogenesis and tumor progression. HIF-1 is a heterodimer of HIF-1alpha, expression of which is controlled by oxygen levels as well as by various oxygen-independent mechanisms, and HIF-1beta (or ARNT), which is constitutively expressed. In this work, we investigate the phosphorylation of the N-terminal heterodimerization (PAS) domain of HIF-1alpha and identify Ser247 as a major site of in vitro modification by casein kinase 1delta (CK1delta). Mutation of this site to alanine, surprisingly, enhanced the transcriptional activity of HIF-1alpha, a result phenocopied by inhibition or small interfering RNA (siRNA)-mediated silencing of CK1delta under hypoxic conditions. Conversely, overexpression of CK1delta or phosphomimetic mutation of Ser247 to aspartate inhibited HIF-1alpha activity without affecting its stability or nuclear accumulation. Immunoprecipitation and in vitro binding experiments suggest that CK1-dependent phosphorylation of HIF-1alpha at Ser247 impairs its association with ARNT, a notion also supported by modeling the structure of the complex between HIF-1alpha and ARNT PAS-B domains. We suggest that modification of HIF-1alpha by CK1 represents a novel mechanism that controls the activity of HIF-1 during hypoxia by regulating the interaction between its two subunits.en
heal.journalNameJ Cell Scien
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Kalousi-2010-Casein kinase 1 regu.pdf1.35 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons